MedicarePartD.guide

A non-government resource built from CMS public data

Hepatitis C drugs on Humana Premier Rx Plan (S5884-164)

Epclusa, Mavyret, Harvoni and their generics, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Missouri
Premium
$126.40/month
Deductible
None
Change plan

2 of 6 Hepatitis C drugs are covered on this plan. All 2 require prior authorization.

4 aren't on the formulary, including sofosbuvir-velpatasvir and Mavyret.

  • Epclusa
    sofosbuvir and velpatasvir
    Covered · prior auth
    from $8,473.21
    Tier 5
  • Vosevi
    sofosbuvir
    Covered · prior auth
    $8,448.19
    Tier 5
Not on the formulary
sofosbuvir-velpatasvir, Mavyret, Harvoni, ledipasvir-sofosbuvir

Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list